跳至主要内容
临床试验/NCT04976231
NCT04976231招募中不适用

Immunophenotyping of Patients With MPS II Treated With Enzyme Replacement Therapy

Duke University1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2022年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
25
试验地点
1
主要终点
Changes in level of T follicular helper cells measured by flow cytometry

研究概览

简要总结

The purpose of this study is to investigate how participant's body's immune system responds to idursulfase, an enzyme replacement therapy (ERT) and find out which types of immune cells are involved in causing untoward responses to the ERT so that the investigators can relate the level of immune response to the treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subject has a confirmed diagnosis of Mucopolysaccharidosis type II (MPS II) or Hunter Syndrome based on enzyme activity and variant analysis.
  • Subject who plan to receive or have received enzyme replacement therapy with idursulfase.

排除标准

  • 未提供

结局指标

主要结局

Changes in level of T follicular helper cells measured by flow cytometry

时间窗: baseline, 1, 3, 6 months

Changes in level of circulation memory B cells measured by flow cytometry

时间窗: baseline, 1, 3, 6 months

Changes in distribution of helper T cells measured by flow cytometry

时间窗: baseline, 1, 3, 6 months

Changes in the frequency of natural killer cells measured by flow cytometry

时间窗: baseline, 1, 3, 6 months

次要结局

未报告次要终点

研究者

发起方
Duke University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验